A renewed understanding of anti-human globulin reagents: interference constraints using an optimization method in pretransfusion compatibility tests.

Affiliation

Wang SS(1), Zhang H(1)(2), Qu L(3), Zhao Z(1)(4), Li L(1)(5).
Author information:
(1)Department of Translational Medicine, The First Hospital of Jilin University, Changchun, China.
(2)College of Pharmacy, Jilin University, Changchun, China.
(3)Department of Pathology, The First Hospital of Jilin University, Changchun, China.
(4)Department of Blood Transfusion, The First Hospital of Jilin University, Changchun, China.
(5)Changchun Bioxun Biotechnology Limited Liability Company, Changchun, China.

Abstract

Anti-human globulin (AHG) reagents are widely applied in pretransfusion compatibility tests. The accuracy of detection with AHG reagents is mainly affected by irregular antibodies or cold agglutinins in blood samples, which are related to the human complement system. Although much has been written about various types and applications of AHG reagents, their characteristics, interference factors and optimal selection in pretransfusion compatibility tests still need to be further clarified. Here, we review clinical practice and basic studies that describe each AHG reagent, summarize the advantages and disadvantages of using different AHG reagents in the presence of cold agglutinins or complement-fixing antibodies, explore the potential mechanisms by which the complement system influences detection with AHG reagents and address the question of how to optimally select AHG reagents for clinically significant antibody detection.